• Publications
  • Influence
Pharmacogenetic determinants of imatinib, dasatinib and nilotinib pharmacokinetics in chronic myeloid leukaemia patients
Imatinib is the gold standard for the treatment of chronic myeloid leukaemia (CML) [1]. Several studies revealed correlation between imatinib trough plasma levels and clinical response, suggestingExpand